title: Commentary: New drugs for atopic dermatitis may provide clues to basic mechanisms of itch and inflammation.
authors.affiliation: Department of Dermatology, Oregon Health and Science University, Portland, Oregon. Electronic address: hanifinj@ohsu.edu.
authors.forename: Jon M
authors.initials: JM
authors.lastname: Hanifin
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005544:Forecasting; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D010726:Phosphodiesterase Inhibitors
keywords: atopic dermatitis; immune responses; inflammation; phosphodiesterase; pruritus